Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
triple-negative breast cancer
Pharma
Roche's new pharma chief talks Tecentriq in early cancers
Roche's new pharma chief Teresa Graham argues Tecentriq is "still in the game" of perioperative lung cancer despite advances by rivals.
Angus Liu
Apr 26, 2023 9:17am
VMLY&R, Gilead use AI to turn patient testimonies into paintings
Feb 16, 2023 10:15am
Gilead gains Trodelvy's Asian rights in $455M deal
Aug 16, 2022 10:35am
AZ's Enhertu could up the pressure on Gilead's Trodelvy: experts
Jul 13, 2022 11:00am
Touch BBCA wants Black women in breast cancer clinical trials
Feb 8, 2022 10:23am
Merck works to raise awareness of triple-negative breast cancer
Oct 25, 2021 10:25am